Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents LM Leoni, B Bailey, J Reifert, HH Bendall, RW Zeller, J Corbeil, G Elliott, ... Clinical cancer research 14 (1), 309-317, 2008 | 486 | 2008 |
Blockade of Wnt‐5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation M Sen, M Chamorro, J Reifert, M Corr, DA Carson Arthritis & Rheumatism 44 (4), 772-781, 2001 | 263 | 2001 |
Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes M Sen, J Reifert, K Lauterbach, V Wolf, JS Rubin, M Corr, DA Carson Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 130 | 2002 |
Amyloid β-mediated cell death of cultured hippocampal neurons reveals extensive tau fragmentation without increased full-length tau phosphorylation J Reifert, DA Hartung-Cranston, SC Feinstein Journal of biological chemistry 286 (23), 20797-20811, 2011 | 107 | 2011 |
Identification of disease-specific motifs in the antibody specificity repertoire via next-generation sequencing RJ Pantazes, J Reifert, J Bozekowski, KN Ibsen, JA Murray, PS Daugherty Scientific reports 6 (1), 30312, 2016 | 52 | 2016 |
Halogenated DOPA in a marine adhesive protein CJ Sun, A Srivastava, JR Reifert, JH Waite The Journal of adhesion 85 (2-3), 126-138, 2009 | 48 | 2009 |
Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology K Kamath, J Reifert, T Johnston, C Gable, RJ Pantazes, HN Rivera, ... Scientific reports 10 (1), 5294, 2020 | 41 | 2020 |
High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19 WA Haynes, K Kamath, J Bozekowski, E Baum-Jones, M Campbell, ... Communications biology 4 (1), 1317, 2021 | 40 | 2021 |
In vitro and ex vivo activity of SDX-105 (bendamustine) in drug-resistant lymphoma cells LM Leoni, B Bailey, CC Niemeyer, J Reifert, H Bendall, L Dauffenbach, ... Cancer Research 64 (7_Supplement), 278-278, 2004 | 35 | 2004 |
Effects of paclitaxel and eribulin in mouse sciatic nerve: a microtubule-based rationale for the differential induction of chemotherapy-induced peripheral neuropathy SJ Benbow, BM Cook, J Reifert, KM Wozniak, BS Slusher, BA Littlefield, ... Neurotoxicity research 29, 299-313, 2016 | 31 | 2016 |
SDX-105 (Bendamustine), a clinically active antineoplastic agent possesses a unique mechanism of action L LM Blood 102, 640a, 2003 | 25 | 2003 |
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro TD Shropshire, J Reifert, S Rajagopalan, D Baker, SC Feinstein, ... Biological chemistry 395 (1), 109-118, 2014 | 23 | 2014 |
SDX-105 (bendamustine is a clinically active chemotherapeutic agent with a distinct mechanism of action N CC Proc Am Assoc Cancer Res 45, 1129, 2004 | 11 | 2004 |
Serum epitope repertoire analysis enables early detection of Lyme disease with improved sensitivity in an expandable multiplex format J Reifert, K Kamath, J Bozekowski, E Lis, EJ Horn, D Granger, ES Theel, ... Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 01836-20, 2021 | 10 | 2021 |
High-resolution mapping and characterization of epitopes in COVID-19 patients WA Haynes, K Kamath, J Bozekowski, E Baum-Jones, M Campbell, ... medRxiv, 2020.11. 23.20235002, 2020 | 10 | 2020 |
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus–Seronegative Recipients of the HSV529 Vaccine K Wang, L Dropulic, J Bozekowski, HL Pietz, S Jegaskanda, K Dowdell, ... The Journal of Infectious Diseases 224 (9), 1509-1519, 2021 | 5 | 2021 |
Mitotic catastrophe induced in cells treated with SDX-105 (Treanda™) C Niemeyer, H Bendall, B Bailey, J Reifert, LM Leoni Proceedings of the American Association for Cancer Research 46, 2291, 2005 | 5 | 2005 |
SDX-105 (Treanda™), Active in Non-Hodgkin’s Lymphoma Cells, Induces the Mitotic Catastrophe Death Pathway. LM Leoni, C Niemeyer, H Bendall, J Reifert, B Bailey Blood, The Journal of the American Society of Hematology 104 (11), 4593-4593, 2004 | 4 | 2004 |
Mechanism of Action and Safety of Second Generation Analogs of SDX-101 (R-Etodolac). LM Leoni, B Crain, B Bailey, M Phillips, H Bendall, Q Chao, J Reifert, ... Blood, The Journal of the American Society of Hematology 104 (11), 3411-3411, 2004 | 4 | 2004 |
SDX-101, a novel chemotherapeutic agent in clinical development, inhibits beta-catenin H Bendall, B Bailey, J Reifert, C Niemeyer, B Crain, D Lu, DA Carson, ... Proceedings of the AACR 45, 2004 | 4 | 2004 |